期刊
CLINICAL JOURNAL OF SPORT MEDICINE
卷 18, 期 3, 页码 282-285出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/JSM.0b013e3181705c8c
关键词
doping control; salbutamol; urine concentration
Objective: The present study was designed to examine the dose-response relationship of inhaled salbutamol and its concentration in the urine while resting at various times after inhalation, and to compare these values against the current World Anti-Doping Code limits. Design: An interventional, repeated-measures design. Setting: Sport Medicine Clinic, University of British Columbia (Vancouver, Canada). Participants: Eight healthy, nonasthmatic males participated in this study (age = 28 +/- 6 years, height = 179.4 +/- 5.1 cm, and weight = 77.4 +/- 5.4 kg). Intervention: Administration of three different doses of inhaled salbutamol (800, 400, and 200 mu g) in a randomized fashion separated by at least 72 hours. Main Outcome Measurement: Urine concentration of non-sulphated salbutamol Results: Urine concentrations were highly variable between subjects and increased as dose increased, with a significant difference noted between 800 and 200 mu g at 30, 60, and 120 minutes after inhalation. Urine concentrations of salbutamol peaked at 60 minutes for all doses. No samples exceeded the doping criterion of 1000 ng/mL, and the maximum value observed was 904 ng/mL. Conclusion: These results indicate that after inhalation of doses up to 800 mu g, urinary concentrations of salbutamol are well below the limits used in doping control.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据